Evidence map›Paper›PMID 27634041›Full record

ArticleThe Journal of biological chemistry2016

Structural Diversity in the Type IV Pili of Multidrug-resistant Acinetobacter.

Kurt H Piepenbrink, Erik Lillehoj, Christian M Harding, Jason W Labonte, Xiaotong Zuo, Chelsea A Rapp, Robert S Munson, Simeon E Goldblum, Mario F Feldman, Jeffrey J Gray and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Bacteriophages targetingFrontiers in microbiology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Signaling inComputational and structural biotechnology journal · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Virulence Factors and Pathogenicity Mechanisms ofAntibiotics (Basel, Switzerland) · 2023
    Review
  19. Article
  20. Type IV Pilus-Mediated Inhibition ofMicrobiology spectrum · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Kurt H PiepenbrinkFrom the Institute of Human Virology and.
Erik LillehojPediatrics, and.
Christian M HardingDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110.
Jason W LabonteDepartment of Chemical and Biomolecular Engineering, Whiting School of Engineering, The Johns Hopkins University, Baltimore, Maryland 21218.
Xiaotong ZuoDepartment of Chemical and Biomolecular Engineering, Whiting School of Engineering, The Johns Hopkins University, Baltimore, Maryland 21218.
Chelsea A RappFrom the Institute of Human Virology and.
Robert S MunsonThe Center for Microbial Pathogenesis in the Research Institute at Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio 43205, and.
Simeon E GoldblumDepartments of Medicine.
Mario F FeldmanDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110.
Jeffrey J GrayDepartment of Chemical and Biomolecular Engineering, Whiting School of Engineering, The Johns Hopkins University, Baltimore, Maryland 21218.
Eric J SundbergFrom the Institute of Human Virology and esundberg@ihv.umaryland.edu.
Johns Hopkins University · USInstitute of Human Virology · NGWashington University in St. Louis · USBipar · FRNationwide Children's Hospital · USPediatrics and Genetics · USUniversity of Maryland, Baltimore · US

Funding

Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
Structure & Function of Clostridium difficile Type IV PiliR01AI114902 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SUNDBERG, ERIC JOHN · 2015 to 2019
$2.6M
Structure and Function of Type IV Pili in Clostridium difficileF32AI110045 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PIEPENBRINK, KURT HENRY · 2014 to 2015
$109k
NIAID NIH HHS F32 AI110045NIAID NIH HHS R01 AI114902NIAID NIH HHS T32 AI095190
6 · The paper itself

Abstract

Acinetobacter baumannii is a Gram-negative coccobacillus found primarily in hospital settings that has recently emerged as a source of hospital-acquired infections. A. baumannii expresses a variety of virulence factors, including type IV pili, bacterial extracellular appendages often essential for attachment to host cells. Here, we report the high resolution structures of the major pilin subunit, PilA, from three Acinetobacter strains, demonstrating that A. baumannii subsets produce morphologically distinct type IV pilin glycoproteins. We examine the consequences of this heterogeneity for protein folding and assembly as well as host-cell adhesion by Acinetobacter Comparisons of genomic and structural data with pilin proteins from other species of soil gammaproteobacteria suggest that these structural differences stem from evolutionary pressure that has resulted in three distinct classes of type IVa pilins, each found in multiple species.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsBacterial ProteinsDrug Resistance, Multiple, BacterialEvolution, MolecularFimbriae, BacterialGammaproteobacteriaGene Expression Regulation, BacterialHumansModels, MolecularPhylogenySoil MicrobiologyBacterial Proteinscell adhesionglycosylationmicrobial pathogenesisprotein foldingtype IV pilix-ray crystallography

Identifiers

PMID27634041
PMCPMC5087714
OpenAlexW2519285438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.